Barclays
OM icon

Barclays’s Outset Medical OM Stock Holding History

Barclays’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.4K Sell
10,792
-26,890
-71% -$110K ﹤0.01% 4384
2025
Q4 		$140K Buy
37,682
+3,356
+10% +$28.8K ﹤0.01% 4477
2025
Q3 		$485K Buy
34,326
+2,026
+6% +$31.6K ﹤0.01% 3831
2025
Q2 		$620K Buy
32,300
+31,788
+6,209% +$496K ﹤0.01% 3637
2025
Q1 		$5.66K Buy
512
+508
+12,700% +$6.06K ﹤0.01% 4928
2024
Q4 		$71 Hold
4
– – ﹤0.01% 5190
2024
Q3 		$43 Hold
4
– – ﹤0.01% 5210
2024
Q2 		$246 Sell
4
-2,325
-100% -$114K ﹤0.01% 4732
2024
Q1 		$77.5K Sell
2,329
-2,245
-49% -$114K ﹤0.01% 4518
2023
Q4 		$371K Buy
4,574
+3,429
+299% +$279K ﹤0.01% 4060
2023
Q3 		$187K Sell
1,145
-43
-4% -$10.1K ﹤0.01% 3331
2023
Q2 		$390K Sell
1,188
-446
-27% -$136K ﹤0.01% 2905
2023
Q1 		$451K Sell
1,634
-27,844
-94% -$10.2M ﹤0.01% 3336
2022
Q4 		$11.4M Buy
29,478
+29,342
+21,575% +$8.27M 0.01% 1142
2022
Q3 		$32K Sell
136
-39,958
-100% -$10.7M ﹤0.01% 3916
2022
Q2 		$8.94M Buy
40,094
+39,574
+7,610% +$17M 0.01% 1059
2022
Q1 		$354K Buy
+520
New +$313K ﹤0.01% 3107

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Barclays's OM Position: Q1 2026 in Review

Barclays reduced its Outset Medical (OM) stake by 71% in Q1 2026, selling an estimated $110K and leaving 10,792 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4384.

Barclays first reported a position in OM in Q1 2022 and has held it in 17 quarters since. The position peaked at $11.4M in Q4 2022. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Barclays held 10,792 shares of Outset Medical worth $41.4K as of Q1 2026.
  • Barclays sold 26,890 Outset Medical shares in Q1 2026, an estimated $110K.
  • Outset Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4384 holding.
  • Barclays first reported a position in Outset Medical in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Outset Medical position peaked at $11.4M in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.